BCDA - BioCardia Inc.
IEX Last Trade
3.18
0.980 30.818%
Share volume: 6,200,977
Last Updated: Fri 30 Aug 2024 09:59:32 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.20
0.98
44.55%
Summary score
31%
Profitability
43%
Dept financing
16%
Liquidity
61%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-37.89%
Return on assets
-44.49%
Return on sales
-3316.18%
Return on invested capital
55.02%
Total debt ratio
49.59%
Debt ratio change over timeo
-0.68%
Current Ratio
7.99%
Quick Ratio
4.72%
Cash Position Ratio
7.89%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
22.08%
Return on assets
-52.15%
Return on sales
-5145.51%
Return on invested capital
128.56%
Total debt ratio
73.56%
Debt ratio change over timeo
-0.47%
Current Ratio
1.81%
Quick Ratio
1.93%
Cash Position Ratio
1.65%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-49.01%
Return on assets
-27.22%
Return on sales
0%
Return on invested capital
101.53%
Total debt ratio
44.46%
Debt ratio change over time
-0.68%
Current Ratio
2.66%
Quick Ratio
0%
Cash Position Ratio
2.44%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-123.92%
Return on assets
-129%
Return on sales
-2030.2%
Return on invested capital
-12.98%
Total debt ratio
-67.95%
Debt ratio change over time
-0.68%
Current Ratio
0.72%
Quick Ratio
0.77%
Cash Position Ratio
0.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCDA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -37.89% | -3.05% | 11.55% | 6.27% |
| Return on assets | -44.49% | 3.6% | 3.57% | 5.27% |
| Return on sales | -3316.18% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 55.02% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 38% | 71% | 64% |
| Total debt ratio | 49.59% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.68% | 6.09% | 6.03% | 1.53% |
| Dept financing | 12% | 50% | 43% | 14% |
| Current Ratio | 1.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 1.93% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.65% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 14% | 31% | 32% |
| Short-term ratios | BCDA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 22.08% | -25.62% | 17.94% | 7.14% |
| Return on assets | -52.15% | 3.26% | 3.67% | 4.71% |
| Return on sales | -5145.51% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 128.56% | 8.14% | 7.17% | 18.16% |
| Profitability | 50% | 40% | 66% | 59% |
| Total debt ratio | 73.56% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.47% | -23.44% | 9.66% | 0.6% |
| Dept financing | 17% | 25% | 45% | 8% |
| Current Ratio | 1.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 1.93% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.65% | 1.48% | 0.76% | 1.49% |
| Liquididy | 55% | 54% | 41% | 73% |